Abbott Laboratories Q4 2024 Earnings Preview
Portfolio Pulse from
Abbott Laboratories is set to report its Q4 2024 earnings on January 22, with an expected EPS of $1.04. The company is praised for its growth strategies and marketing, leading to a maintained buy rating and a price target of $133.90.
January 08, 2025 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abbott Laboratories is expected to report Q4 2024 earnings with an EPS of $1.04. The company is recognized for its strong growth and marketing strategies, leading to a maintained buy rating and a price target of $133.90.
The article highlights Abbott's strong growth and marketing strategies, which are expected to contribute to favorable earnings. The maintained buy rating and price target suggest positive investor sentiment, likely leading to a short-term price increase.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100